摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2,2-Dimethyl-4-phenyl-tetrahydro-pyran-4-yl)-acetic acid | 109878-50-4

中文名称
——
中文别名
——
英文名称
(2,2-Dimethyl-4-phenyl-tetrahydro-pyran-4-yl)-acetic acid
英文别名
2-(2,2-dimethyl-4-phenyltetrahydro-2H-pyran-4-yl)acetic acid;2-(2,2-dimethyl-4-phenyloxan-4-yl)acetic acid
(2,2-Dimethyl-4-phenyl-tetrahydro-pyran-4-yl)-acetic acid化学式
CAS
109878-50-4
化学式
C15H20O3
mdl
MFCD00778615
分子量
248.322
InChiKey
VOWBSUAXGNNDGB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    (2,2-Dimethyl-4-phenyl-tetrahydro-pyran-4-yl)-acetic acid氯化亚砜 、 formamide 作用下, 以 为溶剂, 反应 1.0h, 生成 2,2-dimethyl-4-phenyltetrahydropyran-4-ylcarbonyl chloride
    参考文献:
    名称:
    Synthesis and anticonvulsant activity of substituted tetrahydropyran amides and amines
    摘要:
    DOI:
    10.1007/bf00766251
  • 作为产物:
    参考文献:
    名称:
    Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)
    摘要:
    A series of tetrahydropyranyl (THP) derivatives has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents. Structural modification of the submicromolar hit compound 3 led to the potent 3-methoxy substituted analogue 27. Further SAR development around the THP ring resulted in an additional 10-fold increase in potency, exemplified by analogue 75 with an IC50 of 1.3 nM. Active and potent compounds demonstrated a dose-dependent increase in Ras cytosolic protein. Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI(50)) values ranging from 0.3 to >100 mu M. However, none of the cellular effects observed using ICMT inhibitors were as pronounced as those resulting from a farnesyltransferase inhibitor.
    DOI:
    10.1021/jm200249a
点击查看最新优质反应信息

文献信息

  • ARUTYUNYAN, N. S.;AKOPYAN, L. A.;PARONIKYAN, R. G.;AKOPYAN, N. E., XIM.-FARMATS. ZH., 24,(1990) N, S. 29-31
    作者:ARUTYUNYAN, N. S.、AKOPYAN, L. A.、PARONIKYAN, R. G.、AKOPYAN, N. E.
    DOI:——
    日期:——
  • ARUTYUNYAN N. S.; GARIBYAN K. M.; AKOPYAN L. A.; TOSUNYAN A. O.; VARTYANY+, ARM. XIM. ZH., 39,(1986) N 7, 438-444
    作者:ARUTYUNYAN N. S.、 GARIBYAN K. M.、 AKOPYAN L. A.、 TOSUNYAN A. O.、 VARTYANY+
    DOI:——
    日期:——
  • Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)
    作者:Weston R. Judd、Paul M. Slattum、Khanh C. Hoang、Leena Bhoite、Liisa Valppu、Glen Alberts、Brita Brown、Bruce Roth、Kirill Ostanin、Liwen Huang、Daniel Wettstein、Burt Richards、J. Adam Willardsen
    DOI:10.1021/jm200249a
    日期:2011.7.28
    A series of tetrahydropyranyl (THP) derivatives has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents. Structural modification of the submicromolar hit compound 3 led to the potent 3-methoxy substituted analogue 27. Further SAR development around the THP ring resulted in an additional 10-fold increase in potency, exemplified by analogue 75 with an IC50 of 1.3 nM. Active and potent compounds demonstrated a dose-dependent increase in Ras cytosolic protein. Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI(50)) values ranging from 0.3 to >100 mu M. However, none of the cellular effects observed using ICMT inhibitors were as pronounced as those resulting from a farnesyltransferase inhibitor.
  • Synthesis and anticonvulsant activity of substituted tetrahydropyran amides and amines
    作者:N. S. Arutyunyan、L. A. Akopyan、R. G. Paronikyan、N. E. Akopyan
    DOI:10.1007/bf00766251
    日期:1990.5
查看更多